chr19-54852036-A-G

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate

The NM_006737.4(KIR3DL2):ā€‹c.109A>Gā€‹(p.Thr37Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000528 in 1,609,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…).

Frequency

Genomes: š‘“ 0.000020 ( 0 hom., cov: 32)
Exomes š‘“: 0.000056 ( 0 hom. )

Consequence

KIR3DL2
NM_006737.4 missense

Scores

1
17

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.943
Variant links:
Genes affected
KIR3DL2 (HGNC:6339): (killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 2) Killer cell immunoglobulin-like receptors (KIRs) are transmembrane glycoproteins expressed by natural killer cells and subsets of T cells. The KIR genes are polymorphic and highly homologous and they are found in a cluster on chromosome 19q13.4 within the 1 Mb leukocyte receptor complex (LRC). The gene content of the KIR gene cluster varies among haplotypes, although several "framework" genes are found in all haplotypes (KIR3DL3, KIR3DP1, KIR3DL4, KIR3DL2). The KIR proteins are classified by the number of extracellular immunoglobulin domains (2D or 3D) and by whether they have a long (L) or short (S) cytoplasmic domain. KIR proteins with the long cytoplasmic domain transduce inhibitory signals upon ligand binding via an immune tyrosine-based inhibitory motif (ITIM), while KIR proteins with the short cytoplasmic domain lack the ITIM motif and instead associate with the TYRO protein tyrosine kinase binding protein to transduce activating signals. The ligands for several KIR proteins are subsets of HLA class I molecules; thus, KIR proteins are thought to play an important role in regulation of the immune response. This gene is one of the "framework" loci that is present on all haplotypes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.015002161).
BP6
Variant 19-54852036-A-G is Benign according to our data. Variant chr19-54852036-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 2601860.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KIR3DL2NM_006737.4 linkuse as main transcriptc.109A>G p.Thr37Ala missense_variant 3/9 ENST00000326321.7
KIR3DL2NM_001242867.2 linkuse as main transcriptc.109A>G p.Thr37Ala missense_variant 3/8
KIR3DL2XM_047438795.1 linkuse as main transcriptc.109A>G p.Thr37Ala missense_variant 3/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KIR3DL2ENST00000326321.7 linkuse as main transcriptc.109A>G p.Thr37Ala missense_variant 3/91 NM_006737.4 P2P43630-1
KIR3DL2ENST00000270442.5 linkuse as main transcriptc.109A>G p.Thr37Ala missense_variant 3/81 A2P43630-2

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151706
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000205
AC:
3
AN:
146448
Hom.:
1
AF XY:
0.00
AC XY:
0
AN XY:
80198
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000147
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000151
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000562
AC:
82
AN:
1458116
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
39
AN XY:
725480
show subpopulations
Gnomad4 AFR exome
AF:
0.0000602
Gnomad4 AMR exome
AF:
0.0000449
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000127
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000586
Gnomad4 OTH exome
AF:
0.0000500
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151824
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74226
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000388
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.00000921
AC:
1

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJun 29, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.027
DANN
Benign
0.45
DEOGEN2
Benign
0.0015
T;.
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.0014
N
M_CAP
Benign
0.0012
T
MetaRNN
Benign
0.015
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.52
N;N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
1.3
N;N
REVEL
Benign
0.040
Sift
Benign
1.0
T;T
Sift4G
Benign
0.23
T;T
Polyphen
0.0
B;.
Vest4
0.031
MutPred
0.31
Loss of glycosylation at T37 (P = 0.0133);Loss of glycosylation at T37 (P = 0.0133);
MVP
0.081
MPC
1.7
ClinPred
0.045
T
GERP RS
-1.8
Varity_R
0.023
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs547015379; hg19: chr19-55363491; API